TeselaGen Company

TeselaGen Biotechnology develops DNA design and assembly tools for biology.

Investors Number: 3.0
Total Funding: 4096000.0
Technology: ['BioTech & HealthTech', 'AI Infrastructure']
Estimated Revenue: $1M to $10M
Employee Number: 1-10
Industry: Medical BioTech
Founded Date: 2011-06-01
Headquarters: San Francisco, California, United States
Last Funding Date: 2020-10-14
Last Funding Type: Seed
Investor Type: mike.fero@teselagen.com
Funding Status: Seed